# IMPAVIDO
> **NDA204684** · New Drug Application · Sponsor: KNIGHT THERAPS · Approved 2014-03-19
## Drug
- **FDA Application Number:** NDA204684
- **Application type:** New Drug Application
- **Brand name:** IMPAVIDO
- **Generic name:** MILTEFOSINE
- **Active ingredients:** MILTEFOSINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** KNIGHT THERAPS
- **Manufacturer:** Profounda, Inc.
- **First approval:** 2014-03-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204684)
---
*AI Analytics · CC0 1.0*